mirtazapine has been researched along with Kidney Diseases in 3 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Di Maida, F | 1 |
| Viola, L | 1 |
| Lambertini, L | 1 |
| Mari, A | 1 |
| Mencarini, J | 1 |
| Borchi, B | 1 |
| Carini, M | 1 |
| Zammarchi, L | 1 |
| Minervini, A | 1 |
| Elsisi, AEE | 1 |
| Sokar, SS | 1 |
| Shalaby, MF | 1 |
| Abu-Risha, SE | 1 |
| Sener, MT | 1 |
| Sener, E | 1 |
| Tok, A | 1 |
| Polat, B | 1 |
| Cinar, I | 1 |
| Polat, H | 1 |
| Akcay, F | 1 |
| Suleyman, H | 1 |
3 other studies available for mirtazapine and Kidney Diseases
| Article | Year |
|---|---|
A rare urinary JC virus reactivation after long-term therapy with rituximab.
Topics: Antineoplastic Agents, Immunological; Humans; JC Virus; Kidney Diseases; Linezolid; Lymphoproliferat | 2021 |
Nephroprotective effects of febuxostat and/or mirtazapine against gentamicin-induced nephrotoxicity through modulation of ERK 1/2, NF-κB and MCP1.
Topics: Animals; Anti-Bacterial Agents; Antidepressive Agents; Chemokine CCL2; Drug Synergism; Febuxostat; G | 2021 |
Biochemical and histologic study of lethal cisplatin nephrotoxicity prevention by mirtazapine.
Topics: Animals; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Antioxidants; Blood Urea Nitrogen; | 2012 |